Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedRemoved the government funding lapse notice about NIH Clinical Center's operating status; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe new screenshot shows only minor formatting and wording adjustments on the Study Details page; there are no changes to the core content such as study title, status, eligibility, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedKey updates: version bump to v3.2.0 and the new government-operating-status notice; the previous v3.1.0 reference was removed.SummaryDifference3%

- Check56 days agoChange DetectedThe page now indicates Revision: v3.1.0, replacing the previous v3.0.2. This is a version bump that may reflect feature updates or fixes, but no substantive content changes are shown in the additions/deletions.SummaryDifference0.1%

- Check70 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check77 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.